TGFB2

                                                                                       (Transforming growth factor, beta 2)

Alias                                 (According to NCBI)	transforming growth factor, beta 2 Transforming growth factor beta 2 precursor (TGF-beta 2) (Glioblastoma-derived T-cell suppressor factor) (G-TSF) (BSC-1 cell growth inhibitor) (Polyergin) (Cetermin).
Description    (According to SwissProt)	tgf-beta 2 has suppressive effects on interleukin-2 dependent t-cell growth.
Chromosomal location (According to NCBI, CGH: progenetix)	Location: 1q41 Orientation: Plus strand Size: 95,105 bases 8 Exons DNA Sequence: NT_021877     CGH (1q41): Losses (%) -0.6   Gain (%)  11.7
Mutations and SNPs  (According to HGMD and SNP)	HGMD: SNP: TGFB2
m-RNA                           (According to NCBI and CGAP)	m-RNA Sequence: NM_003238 Size: 1695 bp c-DNA Libraries: TGFB2
Protein                                  (According to SwissProt, Swiss2D, PDB,dbPTM)	Size: 414 amino acids; 47747 Da Catalytic activity: Sub cellular location: Secreted Protein domains:                                                               Protein sequence: P61812 Homologous genes: TGFB2 2D PAGE: 3D Structure: 1TFG PTM: TGFB2
Pathways and interactions (According to BioCarta, DIP)	Pathways: TGF beta signaling pathway Interactions: 5936N
Tissue (According to GeneNote, PubMed, HPA)	Tissue expression: PubMed Reference Human Protein Atlas (HPA) : TGFB2
Clinical                            (According to OMIM, PubMed)	OMIM:190220 PubMed:  Early detection      Diagnosis      Prognosis      Therapy